Tanomastat

CAS No. 179545-77-8

Tanomastat( BAY129566 | BAY 12-9566 )

Catalog No. M12711 CAS No. 179545-77-8

Tanomastat (BAY 129566) is a potent,orally available, non-peptidic inhibitor of MMP-2, MMP-3 and MMP-9 with 11, 143 and 301 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tanomastat
  • Note
    Research use only, not for human use.
  • Brief Description
    Tanomastat (BAY 129566) is a potent,orally available, non-peptidic inhibitor of MMP-2, MMP-3 and MMP-9 with 11, 143 and 301 nM, respectively.
  • Description
    Tanomastat (BAY 129566) is a potent,orally available, non-peptidic inhibitor of MMP-2, MMP-3 and MMP-9 with 11, 143 and 301 nM, respectively; inhibits extracellular matrix degradation and potentially inhibiting angiogenesis, tumor growth and invasion, and metastasis both in vitro and in vivo.Ovarian Cancer Phase 3 Discontinued.
  • In Vitro
    Tanomastat (BAY 12-9566) (1-10000 nM; 6 hours) prevents matrix invasion by endothelial cells in a concentration-dependent manner (IC50=840 nM), without affecting cell proliferation.Tanomastat (BAY 12-9566) (1-00 μM; 5 days) inhibits tubule formation completely at 15-100 μM.
  • In Vivo
    Tanomastat (BAY 12-9566) (100 mg/kg; p.o.; daily for a 7-week period) inhibits local tumor regrowth without causing any toxic effect, and inhibits the number and volume of lung metastases. Animal Model:Six- to eight-week-old female BALB/c nude mice (bearing MDA-MB-435 cells) Dosage:100 mg/kg Administration:p.o.; daily for a 7-week period Result:Inhibited local tumor regrowth by 58% without causing any toxic effect, and inhibited the number and volume of lung metastases by 57 and 88%, respectively.
  • Synonyms
    BAY129566 | BAY 12-9566
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP
  • Research Area
    Cancer
  • Indication
    Ovarian Cancer

Chemical Information

  • CAS Number
    179545-77-8
  • Formula Weight
    410.912
  • Molecular Formula
    C23H19ClO3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)[C@@H](CSC1=CC=CC=C1)CC(C2=CC=C(C3=CC=C(Cl)C=C3)C=C2)=O
  • Chemical Name
    (S)-4-(4'-chloro-[1,1'-biphenyl]-4-yl)-4-oxo-2-((phenylthio)methyl)butanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gatto C, et al. Clin Cancer Res. 1999 Nov;5(11):3603-7. 2. Rowinsky EK, et al. J Clin Oncol. 2000 Jan;18(1):178-86. 3. Leung D, et al. J Med Chem. 2000 Feb 10;43(3):305-41. 4. Moore MJ, et al. J Clin Oncol. 2003 Sep 1;21(17):3296-302.
molnova catalog
related products
  • S-methyl-KE-298

    S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from ?rheumatoid arthritis (RA) synovial cells.

  • Colistimethate Sodiu...

    Colistimethate Sodium is used for the treatment of serious infections due to selected aerobic Gram-negative pathogens in patients with limited treatment options.

  • Andecaliximab

    Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis.